7 days to start developing antibodies. 21 days optimal. I googled it. This was for an infection but I can't see why it would be any different for a vaccine.I was told 21 days last thursday for the AZ
7 days to start developing antibodies. 21 days optimal. I googled it. This was for an infection but I can't see why it would be any different for a vaccine.I was told 21 days last thursday for the AZ
Wow that's scary ..If anything shows how quickly this spreads look at the Isle of Man. No cases for months and now they have 800 cases.
It's one in a hundred of the population, same sort of levels we've seen recently. Thankfully, recent days have seen falls in number of new cases, suggesting some regaining of control.Wow that's scary ..
Astrazeneca need to provide a better explanation for these blood clots issues because it is already putting considerable doubts in people's minds. Correlation doesn't equal causation as they say but just a blanket statement "it isn't us" isn't re-assuring people.
Astrazeneca need to provide a better explanation for these blood clots issues because it is already putting considerable doubts in people's minds. Correlation doesn't equal causation as they say but just a blanket statement "it isn't us" isn't re-assuring people.
What else can they possibly say other than what their database shows?
Someone has to explain the correlation of timings and the fact that instances and other long-term effects of the vaccine are being under-reported. There are people I know who had the vaccine a couple of weeks ago and are still suffering temperature fluctuations, inability to sleep and are just being fobbed off with "it's normal", when it isn't. Equally, the majority are absolutely fine but that doesn't mean we shouldn't give properly detailed reasoning to quell any worries, because when it comes to something as important as the vaccine these questions should be willingly and openly answered given the level of trust given in taking them.From the BBC website:
What did AstraZeneca say?
It said there was no evidence of an increased risk of clotting due to the vaccine.
It said that across the EU and United Kingdom there had been 15 events of deep-vein thrombosis (DVT) - a blood clot in a vein - and 22 events of pulmonary embolism - a blood clot that has entered the lungs - reported among those vaccinated.
AstraZeneca said these figures were "much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed Covid-19 vaccines".
"The nature of the pandemic has led to increased attention in individual cases and we are going beyond the standard practices for safety monitoring of licensed medicines in reporting vaccine events, to ensure public safety," Ann Taylor, the firm's chief medical officer, said.